en 31379993 <p>Background: Although <em>Saccharomyces cerevisiae</em> has several industrial applications, there are still fundamental problems associated with sequential use of carbon sources. As such, glucose repression effect can direct metabolism of yeast to preferably anaerobic conditions. This leads to higher ethanol production and less efficient production of recombinant products. The general glucose repression system is constituted by <em>MIG1</em>, TUP1 and SSN6 factors. The role of <em>MIG1</em> is known in glucose repression but the evaluation of effects on aerobic/anaerobic metabolism by deletion of <em>MIG1 </em>and constructing an optimal strain brand remains unclear and an objective to be explored.&nbsp;<br /> Methods: To find the impact of <em>MIG1</em> in induction of glucose-repression, the Mig1 disruptant strain (∆<em>MIG1</em>) was produced for comparing with its congenic wild-type strain (2805). The analysis approached for changes in the rate of glucose consumption, biomass yield, cell protein contents, ethanol and intermediate metabolites production. The <em>MIG1</em> disruptant strain exhibited 25% glucose utilization, 12% biomass growth rate and 22% protein content over the wild type. The shift to respiratory pathway has been demonstrated by 122.86 and 40% increase of glycerol and pyruvate production, respectively as oxidative metabolites, while the reduction of fermentative metabolites such as acetate 35.48 and ethanol 24%.&nbsp;<br /> Results: Results suggest that ∆<em>MIG1</em> compared to the wild-type strain can significantly present less effects of glucose repression.&nbsp;<br /> Conclusion: The constructed strain has more efficient growth in aerobic cultivations and it can be a potential host for biotechnological recombinant yields and industrial interests.</p> Saccharomyces cerevisiae, Homologous recombination, Metabolic pathways, Yeasts 215 220 https://www.ajmb.org/En/Article.aspx?id=10377 https://www.ajmb.org/PDF/En/FullText/10377.pdf IrajAlipourfardCenter of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna, Vienna, Austria11436NellyDatukishviliInstitute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia11437SalarBakhtiyariDepartment of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran31491KarimehHaghaniDepartment of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran31492LauraDi RenzoSection of Clinical Nutrition and Nutrigenomics, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy11438Renatade MirandaCAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil11439DavidMikeladzeInstitute of Chemical Biology, Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi, Georgia11440